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Non-technical summary 
R&D co-operation has become an important organisational component in the 
innovation process. In recent years more and more firms have become involved 
in collaborative relationships with a variety of partners, from suppliers to 
customers and research institutes. The trend towards R&D co-operation has 
motivated researchers to empirically investigate the effects related to 
collaboration in firms. Most of them have dealt with input related motives for 
and effects surrounding R&D co-operation at the firm level, which include 
knowledge spillovers, access to complementary knowledge or cost- and risk-
sharing in innovation projects. The output or rather the outcome of a co-operative 
agreement in terms of technological and economic success is at least equally 
important. In order to evaluate an R&D co-operation economically, its effect on 
the firm’s economic success should be measured. 
This paper contributes to the empirical work on the benefits of R&D co-
operation by assessing how much firms profit from co-operative agreements with 
external partners. In so doing we distinguish between the specific contributions 
of four different co-operation partners: customers, suppliers, competitors and 
research institutions. We investigate the effect of past R&D co-operation on 
current success with innovations (sales of innovative products and cost 
reductions due to process innovations). Specific attention will be given to the 
effect of R&D co-operation on cost reductions brought about by innovations, a 
topic widely discussed in the theoretical literature but neglected until now in the 
empirical literature on the output of co-operation. 
Our empirical analysis rests on firm level data from the annual German 
innovation survey, using two consecutive waves of the survey (Mannheim 
Innovation Panel of 2004 and 2005), which covers service and manufacturing 
industries. We apply a censored regression model to the data and find that R&D 
cooperation has a positive impact on the success of process innovations and sales 
of products new to the market, but no significant effect on sales of product 
imitations. By distinguishing between co-operations with different types of 
partners, we identify co-operation with competitors as being profitable in terms 
of cost reduction. If firms aim to develop products new to the market, co-
operations with research institutes are helpful. However, we found no evidence 
of any positive effect of cooperation with competitors on the share of total sales a 
firm achieves with market novelties. R&D co-operations with suppliers and 
customers do not have a significant impact on any of the three measures of 
success.  
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Abstract 
In this paper we analyse the effect of R&D co-operation on firms’ innovation 
performance. We investigate the effect of past co-operation on current sales of 
innovative products, distinguishing between products new to the firm and new to 
the market, and on cost reductions due to innovative processes. Particular 
attention is paid to the impact of different co-operation partners. The analysis 
rests on firm-level data from two consecutive waves of the annual German 
innovation survey. We find that innovative firms that cooperate have a higher 
share of turnover with market novelties and a higher share of cost reduction due 
to process innovations than non-cooperating firms. In particular, R&D co-
operation with research institutes has a positive influence on a firm's economic 
success with market novelties, while R&D co-operation with competitors leads to 
an increase in the cost reduction attributable to innovative processes. 
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1 Introduction 
Co-operation has become an important organisational component of the 
innovation process. In recent years more and more firms have become involved 
in collaborative relationships with a variety of partners, from suppliers to 
customers and research institutes. This surge in co-operative agreements 
pertaining to innovation activities has been documented by Hagedoorn (2002) 
among others. In addition, public support policies adopted by national authorities 
and the European Union since the end of the 1980s (e.g. BMBF 1988) have 
explicitly encouraged the formation of co-operations in R&D and innovation 
projects. The trend towards co-operation has motivated researchers to empirically 
investigate the causes and effects of collaboration in firms (e.g. Cassiman and 
Veugelers, 2002). Most of them have dealt with input related motives for and 
effects related to R&D co-operation at the firm level, which include knowledge 
spillovers, access to complementary knowledge or cost- and risk-sharing in 
innovation projects. As these inputs into the innovation process have become 
more important in recent years so has co-operation. 
However, the motives for firms to cooperate in R&D are not restricted to the 
input side. The output or rather the outcome of a co-operative agreement in terms 
of technological and economic success is at least equally important. In order to 
evaluate economically an R&D co-operation, its effect on the firm’s economic 
success should be measured. Firms benefit from a co-operation if the co-
operation positively affects their economic success sufficiently that it can be 
assumed that the costs of a co-operation, e.g. transaction costs, are outweighed. 
Thus, it is important to analyse the effects of co-operation on outcome measures 
in addition to its effects on inputs. 
In the theoretical literature considerable effort has been put into the 
identification of the effects and benefits of co-operation. D'Aspremont and 
Jacquemin’s (1988; 1990) model has been the basis for many other researchers 
investigating the effect of co-operation and spillovers on R&D investment, 
output and profits. Empirical literature on the innovative and economic success 
of R&D co-operation is still relatively scarce but has been growing in recent 
years (see e.g. Lööf and Broström, 2004; Belderbos et al., 2004b). 
This paper contributes to the empirical work on the benefits of co-operations on 
the outcome side by assessing the extent to which firms profit from forming co-
operative agreements with external partners. In so doing we distinguish between 
the specific contributions of four different co-operation partners. In contrast to 
other studies, which are concerned with the effect of R&D co-operation on 
productivity and spillovers (e.g. Cincera et al., 2003; Belderbos et al., 2004b), 
our goal is to investigate the effect of past co-operation on current success with 
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innovations (sales of innovative products and cost reduction due to process 
innovations). Specific attention will be given to the effect of co-operation on cost 
reduction due to innovations, a topic widely discussed in the theoretical literature 
but neglected until now in the empirical literature on the output of co-operation. 
The following section provides a review of the literature on the input and 
output related effects of co-operation in innovation. Section 3 discusses the 
hypotheses to test and is followed by section 4 in which the data used is 
described and the empirical specification presented. In section 5 the empirical 
results are discussed before we draw conclusions in section 6. 
2 Related Literature on the Benefits of Co-operation 
Below we provide an overview of the theoretical and empirical studies of R&D 
co-operation. This section mainly focuses on the effects of R&D co-operation on 
the inputs of firms’ innovation processes and the effect of R&D co-operation on 
the outcome in terms of technological and economic success. The effects of co-
operation on social welfare are not included in this review, since our main focus 
is on the effects of R&D co-operation on individual firms. 
Effect of R&D co-operation on inputs for the innovation process 
A starting point for the analysis of possible effects of co-operation on firms’ 
(innovation) performance is the input-related motives firms have for cooperating 
with external partners. They represent the firms’ expectations regarding the 
benefits from cooperating on the input side of the innovation process. These 
motives have been analysed in many theoretical and empirical papers. 
A central motive for firms to cooperate on R&D is the internalization of 
spillovers: Katsoulacos and Ulph (1998) build a theoretical model where 
spillovers are endogenous and state that it is essential for the understanding of the 
impact of research joint ventures on innovation performance to consider 
endogenous spillovers, i.e. spillovers that arise because firms co-operate. Steurs 
(1995) carries out numerical simulations of a theoretical model. He finds that for 
higher levels of intra- and inter-industry spillovers the expected output-related 
benefits of (inter-industry) R&D co-operation are higher. De Bondt (1996) 
conducts a review of theoretical studies that investigate the effect of spillovers on 
innovation activities of firms. He states, among other things, that firms can 
increase their profits if they manage to improve spillovers through co-operation. 
In this sense his study provides a link between the effects on inputs of R&D co-
operation and those on outputs, which will be discussed below. Empirical studies 
have confirmed that generating knowledge inflows and prohibiting knowledge 
outflows are indeed important motives for - and consequently expected benefits 
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of - co-operation (e.g. Cassiman and Veugelers, 2002; Belderbos et al., 2004a; 
Schmidt, 2005; Lopez, 2003).  
Another motive for and benefit of co-operation that is closely related to 
knowledge flows is access to external knowledge that is complementary to one’s 
own (Hagedoorn, 1993). Hite and Hesterly (2001) argue that firms establish 
networks because they assume that they will benefit from the complementary 
assets and competencies their respective partners within the network can 
contribute. Scott, 1996 study indicates that co-operation leads to research in areas 
that would not have been on the firms “R&D horizon” without co-operation, 
providing evidence that the partner in the co-operation contributes 
complementary rather than similar knowledge. 
Besides knowledge spillovers, resource constraints play an important role as a 
motive for co-operation. The most prominent example for this group of motives 
is the sharing of costs and risks among partners in the co-operative agreement 
(Sakakibara, 1997). The reduction of costs for the development of new processes 
and products through R&D co-operation can be interpreted as a benefit for the 
partners, because it reduces the inputs required to end up with the same output.  
An overview of the empirical evidence on the link between expected and actual 
benefits of co-operation has been provided by Caloghirou et al. (2003). They cite 
their own empirical study (Caloghirou and Vonortas, 2000), which found that 
among European firms’ expected benefits from co-operation were 
“acquisition/creation of new knowledge” and “acceleration of existing research” 
(Caloghirou et al., 2003: 559). The review of arguments for R&D partnerships by 
Hagedoorn et al. (2000) concludes that the expected results of research 
partnerships usually meet the initial incentives for forming the partnership. 
Furthermore, that co-operation can indeed lead to a reduction of costs of 
innovation activities has been shown by Beath et al. (1998). One of the results of 
their theoretical model is that “a Research Joint Venture (RJV) will economize 
on scarce R&D resources” (Beath et al., 1998: 47).  
Effect of R&D co-operation on technological and economic success 
The literature cited above mostly deals with the anticipated immediate effect of 
co-operation on the inputs for innovation activities, e.g. expecting higher 
spillovers or lower costs than other firms. These direct effects on inputs are not 
the only ones, however. It is reasonable to assume that R&D co-operation also 
affects the technological and economic success of firms.1 Two ways of 
measuring technological success are the quality of products and improvements in 
the productivity of research. A usual measure of economic success is the 
                                                 
1 For a discussion of additional measures of innovative success see Janz (2003) and Caloghirou et al. 
(2003). 
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performance in terms of the share of sales from innovative products, cost 
reductions through innovations2 or profits. 
The quality of products as a dimension of the technological success of 
innovation activities and co-operation has not drawn a lot of attention from 
(empirical) researchers, mainly because the large innovation surveys (e.g. 
Community Innovation Survey) provide little if any information about the 
technological features of the innovations developed by firms. One technological 
feature that can be investigated using innovation surveys, however, is the novelty 
of innovations. Landry and Amara (2002) find that the novelty of innovations 
increases with the use of a larger variety of sources of information and 
collaborative agreements with external partners. Monjon and Waelbroeck (2003) 
include a wide range of collaboration variables and distinguish between domestic 
and foreign co-operation as explanatory variables for the novelty of innovations. 
They find a positive impact of co-operation with domestic equipment suppliers 
and foreign (EU) universities and a negative impact of co-operation with foreign 
(EU) equipment and software suppliers on the novelty of innovations. However, 
only 4 of the 24 dummies for co-operation included are significant at the 95% 
level in their model. 
The effects of spillovers and co-operation on the productivity of research 
(another measure of technological success) have been analysed in many 
empirical studies. Griliches (1979; 1992) argues that R&D spillovers have a 
positive impact on productivity, as does Jaffe (1986). Nesta and Mangematin 
(2004) report that biotech firms that source knowledge through collaborative 
agreements perform better, in terms of patent applications, than those who do 
not. Love and Roper (2004) show that sourcing knowledge from external 
partners positively affects firms’ innovation success in terms of sales of 
innovative products introduced in the previous three years. 
As Klomp and van Leeuwen (2001) have shown, building on the model of 
Kline and Rosenberg (1986), there is a strong link between innovation 
performance and firm performance. Higher probabilities of success of innovation 
projects and more novel innovations usually lead to greater economic success for 
firms. 
This brings us to the second group of success measures, the economic success 
of innovation activities. Kamien et al. (1992) analyse the effects of research joint 
ventures on welfare under Cournot and Bertrand competition and find that 
regardless of the type of competition assumed “an RJV [Research Joint Venture] 
cartel dominates […] as it yields the highest per-firm profit” (Kamien et al. 1992: 
                                                 
2 Note that the cost reduction is the result of an improved process (outcome of the innovation process) 
here and not the result of a reduction of costs for the development of an innovation (cost-sharing). 
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1303).3 In the theoretical models building on D'Aspremont and Jacquemin (1988; 
1990), where firms either cooperate in the pre-competitive stage and are rivals in 
the market or cooperate at both stages, R&D externalities occur and result in cost 
reductions or product improvements and higher firm profits if the level of 
spillovers is high enough (Kamien et al., 1992; Suzumura, 1992; Vonortas, 1994; 
De Bondt and Veugelers, 1991). This so called non-tournament literature argues 
that the benefits from co-operation for firms and society arise from cost-
reductions that can spill over to other firms in the economy. Their argument is 
based on the assumption that more R&D always leads to lower costs. Most 
authors find that the aggregate R&D level is indeed higher with co-operation 
than without, if spillovers are significantly high. Consequently R&D co-
operation is beneficial for firms. 
The theoretical studies focus on the mechanisms by which co-operations affect 
(economic) success measures directly and indirectly, e.g. via spillovers.4 Most of 
the empirical studies basically treat the mechanism as a black-box and directly 
analyse the difference in economic success between firms that cooperate and 
those that do not. 
A recent contribution to this literature is made by Belderbos et al. (2004b) who 
analyse data on the innovation behavior of Dutch firms. They distinguish 
between four types of co-operation and find that R&D collaboration with 
competitors and universities increases the growth of sales attributable to market 
novelties, while co-operation with suppliers and competitors leads to a growth of 
value added per employee. Cincera et al.’s (2003) empirical study shows that 
international R&D co-operation positively affects a firm’s productivity growth. 
Lööf and Broström (2004) find that collaboration between universities and firms 
not only increases the probability that firms will apply for a patent but also has a 
positive impact on innovative sales per employee. Gemünden and Ritter (1997) 
investigate the relationship between sales due to product innovations and cost 
reductions through process innovations using data from the Mannheim 
Innovation Panel (MIP). Based on descriptive analysis, they find that cooperating 
firms have higher sales attributable to product innovations than non-cooperating 
firms. Their study is the only one we are aware of that includes a direct measure 
for a firm’s success with process innovations.5 Two empirical studies based on 
the first waves of the MIP in the manufacturing sector also show that cooperating 
firms perform better in terms of innovative sales than other firms (König et al., 
1994; Felder et al., 1994). While Felder et al. (1994) only provide descriptive 
                                                 
3 For additional theoretical models investigating the effect of co-operation and RJVs on profits see the 
review by De Bondt (1996). 
4 Pittaway et al. (2004) review the literature on the benefits of networks and provide an overview of 
mechanisms by which networking can positively influence the output of innovation activities. 
5 The lack of empirical research on the cost-reducing effects of R&D co-operation as a topical issue in 
the theoretical literature can partially be explained by a lack of data. Up until now, only the German 
innovation survey has contained a question on cost-reducing process innovations. 
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statistics on the relationship between R&D co-operation and the share of turnover 
from product innovation, König et al. (1994) conduct a multivariate analysis, 
which is limited to manufacturing firms6. They do not include an indicator for 
each type of co-operation partner in their study, but rather the number of different 
types of partners.  
In contrast to these findings, Siebert’s (1996) analysis of 314 US research joint 
ventures reveals that cooperating firms have lower profit margins than non-
cooperating firms. This result, which is largely based on descriptive statistics, is 
one of the few studies we are aware of that states that co-operation might have a 
negative effect on profits. Another one is by Berg et al. (1982). They find that 
firms participating in R&D joint ventures have a lower profitability than those 
who do not. 
Some other studies have included variables for co-operation in their models 
explaining innovative sales.7 The evidence from these studies is mixed. Klomp 
and van Leeuwen (2001) for example find a positive impact of a co-operation 
dummy on the innovation output of firms in a single equation model. In their 
simultaneous equation model, the effect is only marginally significant, however. 
Another study is by Janz et al. (2003). They analyse the determinants of 
innovation performance in Sweden and Germany and include variables for co-
operation among firms in their equation for the determinants of innovation sales 
per employee. They find no significant impact of R&D co-operation with 
suppliers, customers, universities or research institutes on innovation 
performance in the same period. They find that R&D co-operation with 
competitors has a negative effect on innovative sales. 
3 Analytical Framework and Hypotheses 
The literature review suggests that the benefits of R&D co-operation could be 
investigated either directly, i.e. by treating the mechanism through which co-
operation influences performance as a “black box”, or indirectly, by considering 
the impact of co-operation on inputs such as spillovers and research costs first 
and then looking into how it affects the benefits, as shown in figure 1. We will 
adopt the former approach in our study, i.e. we will analyse the effect of co-
operation on direct economic success without looking at the intermediate 
mechanism by which R&D co-operation affects the innovation input. 
                                                 
6 A large scale survey on the innovation behaviour of firms in the service sector was first undertaken in 
1996 in Germany. 
7 Note that the co-operation dummy is one of the determinants of innovative success included in these 
studies, but no detailed analysis is carried out regarding this dummy since co-operation is not their 
main focus. 
 7
A similar approach has been followed by Belderbos et al. (2004b) and 
Cincera et al. (2003). They both use firm level data on R&D and innovation 
activities. Belderbos et al. (2004b) look at the effect of different types of 
cooperation on the growth of value added per employee and the growth of new-
to-the-market sales per employee over a six year period. Cincera et al. (2003) 
investigate the direct effect of R&D co-operation on output growth. The success 
measures these authors use mostly focus on the effects of product innovation or 
innovation in a broader sense. Our study differs from Belderbos et al. (2004b) 
and Cincera et al. (2003) by including a direct measure of the success firms 
achieve thanks to process innovations, i.e. cost reductions due to process 
innovations. 
Figure 1: Effects of co-operation on innovation input, output and success 
 
 
 
 
The review of the literature shows that cooperation has a broad spectrum of 
impacts on the success of innovations and companies. In our paper we take this 
into account and investigate the link between R&D co-operation and success 
along three dimensions: sales of product innovations which are not new to the 
market, sales of market novelties, and cost reduction due to process innovations. 
In doing so, we restrict the analysis to the direct economic success of innovations 
and firms. We could also have included the technological success of innovation 
activities, measured with respect to the innovations’ degree of novelty, in our 
model. We think, however, that some of this effect will be picked up by the sales 
attributable to product innovations and the cost reduction due to process 
innovations. We assume that the more novel a product or process innovation is 
the more turnover it contributes or the more cost reduction can be achieved, 
respectively. Taking our lead from the literature, we adopt an optimistic view of 
R&D co-operation and expect all three success measures to be positively 
influenced by R&D co-operations. 
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As far as different types of co-operation partners are concerned, we expect the 
following: Regarding cost reductions we suppose that R&D co-operations with 
competitors or suppliers in particular will have a positive impact. Since suppliers 
deliver inputs for the process of production in the form of knowledge and 
technology, co-operating with them might bring enhancements to this process, 
leading to cost reduction (cf. Belderbos et al., 2004b). Competitors might have 
similar processes and might work together in order to improve them. For 
example, in the automobile industry, cars from different manufacturers are 
sometimes built on the same platform which has been developed collectively. 
This contributes to reducing costs.  
R&D co-operations with customers probably focus more on product 
innovations. Since customers are the recipients of the products or services, they 
know what they need or want and hence, co-operations with them are target-
oriented towards improved products and reduce the risk associated with the 
acceptance or otherwise of the improved or new product. The latter reason is also 
mentioned by Tether (2002). Co-operations with research institutions might be 
targeted at more basic research and be long-term oriented. They would thus not 
have an immediate significant effect in the year after the co-operation. If they 
have an effect, they might be especially successful in the production of market 
novelties (cf. Tether, 2002).  
Measuring the impacts of R&D co-operation on the economic success of firms 
is not without problems. Caloghirou et al. (2003) provide a discussion of the 
“thorny issues regarding both methodology and measurement of outcomes of 
collaboration” (Caloghirou et al., 2003: 557). They state that the measurement of 
outcomes is not specific to collaborations but is one of the problems surrounding 
the measurement of the performance of organisations in general. One of his 
concerns is that performance is affected by changes in firms’ environments and 
not only by collaboration. We cannot fully control for this problem, since we do 
not have enough information on the environment the firms work in, e.g. with 
respect to the competition firms are facing, the regulatory framework, or what 
funding for R&D activities is available to firms. The only thing we know is their 
location in East or West Germany, which is a broad proxy for different business 
environments. The distinction between indicators and determinants is less 
problematic in our study, since all three of our success measures are clearly 
indicators of innovative success rather than determinants. 
Another methodological issue is the time lag between co-operation and its 
impact on innovation success measures. Belderbos et al. (2004b) for example 
argue that the mixed results of the studies on the impact of co-operation on 
innovative sales are due to the difference in time lags used in these studies. We 
support this argument, as it is reasonable to assume that R&D co-operation (in 
particular pre-competitive co-operation) does not contribute to innovative 
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performance right away, but rather in subsequent periods. Even if firms 
cooperate in the product market it might take some time for the positive effect of 
co-operation to set in, especially if firms cooperate in the introduction and 
marketing of innovative products, which are still at the beginning of their life 
cycle. The time lag between co-operation and its effects may also vary with the 
type of co-operation partner. To give an example, R&D co-operation with 
research institutes is usually more focused on basic research and technologies. 
The results of these research activities take longer to be implemented in 
innovative products and processes than the results of more applied research 
undertaken with competitors or customers. 
The literature cited above does not give an indication of the duration of the time 
lag between co-operation and the impact on firms’ success. We investigate the 
impact of co-operation in the year after the co-operation took place. 
4 Data and Empirical Model 
To test the hypotheses mentioned above, we use data from the Mannheim 
Innovation Panel (MIP). This annual survey on the innovation activities of firms 
with 5 or more employees is conducted by the Centre for European Economic 
Research (ZEW) on behalf of the German Federal Ministry of Education and 
Research (BMBF).8 
For our analysis we use the 2004 survey, in which data was collected on the 
innovation behaviour of enterprises during the three-year period 2001-2003, and 
the innovation survey of 2005 (reference period 2002-2004). The MIP surveys 
use the European-wide harmonized methodology for the so called “Community 
Innovation Survey (CIS)” which is based on the Oslo Manual (OECD and 
Eurostat, 1997). The 2005 MIP survey was the German part of the fourth 
Community Innovation Survey. About 4,500 firms in manufacturing and services 
responded each year to the voluntary mail surveys, providing information on 
their innovation activities. 
The dependent variables measuring innovation success can only be positive if 
the firm is an innovator, i.e. the firm has introduced at least one product or 
process innovation during the three-year period 2002 to 2004. We restrict our 
analysis to these innovating firms and look at their R&D co-operation behaviour 
in the years before 2002. Additionally, the firms had to provide all the 
information we needed to construct our other explanatory variables. Of the 1,900 
firms that answered both surveys (2004 and 2005 survey), exactly 699 
enterprises fit these criteria. 
                                                 
8 For a more detailed description of the MIP survey see Janz et al. (2001) or Rammer et al. (2005). 
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Construction of the variables used9  
As explained above, we use three variables to quantify the direct economic 
success of the firms: the reduction of the average costs for a company in 2004 
due to new or significantly improved processes introduced between 2002 and 
2004 (REDP), the share of sales in 2004 with significantly improved products or 
products new to the firm (but not new to the market) introduced between 2002 
and 2004 (IMIP), and the corresponding share due to market novelties (NOVP). 
The latter two groups are mutually exclusive, depending on whether the product 
innovation is just new to the firm or new to the market. 
Our main research question is whether cooperative R&D activities in the past 
have an impact on the firm’s innovation success. First, we use an overall R&D 
co-operation dummy (COOP) which indicates whether a firm cooperated at all 
(with customers, suppliers, competitors or research institutes) during the three 
year period 2001-2003. Secondly, we divide the co-operations into different 
groups based on the partner and distinguish between co-operations with 
customers (CO_CU), with suppliers (CO_SU), with competitors or firms from 
the same sector (CO_CO) and with universities or institutional research firms 
(CO_IN). We expect differences in the impact of the various types of cooperative 
R&D on the specific success measures.  
In order to explain the firm’s innovation success with product and process 
innovations we also consider other variables in our empirical model which might 
have an impact10: 
In line with previous studies, an important variable to explain the innovative 
success is the innovation expenditure intensity (ININT), measured as innovation 
expenditure (in thousand EURO) divided by the number of employees. The 
expected effect of this variable is positive, i.e. the higher the innovation 
expenditure, the higher the share of new and up-to-date products and the higher 
the success with innovations. The innovation intensity is included as lagged 
variable in order to mitigate simultaneity problems. In order to control for a non-
linear relationship the squared intensity is also included in the regressions 
(ININT2).  
A measure for the orientation of firms’ R&D activities is included. We use the 
R&D staff, i.e. employees who are engaged in R&D activities, as a measure of 
the R&D orientation and argue that if a firm has R&D personnel its R&D 
orientation is longer-term than if it has not. Instead of including the number of 
                                                 
9 A detailed description of the construction of the variables included in our empirical model can be found 
in table 5 in the appendix. 
10 A noteworthy share of R&D co-operations with research institutes might be publicly funded. Since we 
are not interested in the effect of public funding and other motives on firms’ decisions to engage in 
R&D co-operation, but rather the impact of established co-operations on the success of firms, we do 
not include a variable for public funding in our analysis. 
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R&D employees, which would be a measure similar to the innovation intensity, 
we capture the long-term orientation of R&D with a dummy variable 
(RDEMPD), which equals one if the company has any R&D employees. 
The innovation expenditure intensity and the R&D orientation of a firm also 
control partially for the absorptive capacity of firms. However, as Cohen and 
Levinthal (1990) have argued, a firm’s absorptive capacity is also dependent on 
its employees’ absorptive capacity. In order to take this aspect into account, the 
share of highly qualified employees, i.e. employees with a university degree, is 
included in our empirical model (HQUAL). The higher the share, the higher the 
ability to absorb and exploit external knowledge. This ability is seen as a critical 
factor in the innovation processes of firms (see e.g. Fagerberg, 2005) and is 
necessary to develop high-quality product or process innovations. We therefore 
expect a positive impact on the economic success measures.  
We also control for the export intensity (EXINT) since firms that are active on 
the international market face tougher competition abroad than at home. This 
might bring pressure to cut costs in the manufacture of products or provision of 
services in order to stay competitive. By going abroad they also might learn from 
their foreign competitors how to improve their production processes and cut 
costs. In both cases the effect of the export intensity on cost reduction through 
process innovations would be indirect rather than direct. In addition, the foreign 
market might also increase demand for the products or services. In order to 
control for endogeneity, we use a lagged variable.  
Finally, some firm characteristics that potentially influence a firm’s success 
with product and process innovations are included in our model. We control for 
the firm size by using the logarithm of the number of employees (LNEMP). We 
test the effect of being part of group by means of the dummy variable GROUP. 
The firm’s age (LNAGE) is included to take into account the possibility that the 
share of new products might be especially high for young firms. This is because 
they are not yet as well-established and have just developed their first products, 
which are new to the firm or even new to the market. In addition, we control for 
firms located in Eastern Germany (EAST). It has been shown that the innovation 
activities of East German firms still differ from West German ones (see e.g. 
Aschhoff et al., 2006). We include dummies for twelve industries (IND1–IND12) 
in the regressions in order to capture industry-specific effects. IND1 serves as the 
base category. 
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Descriptive statistics 
Descriptive statistics of the variables used in the regressions are presented in 
table 1, divided in cooperating and non-cooperating firms.11 On average, the non-
cooperating firms reduced costs by two per cent in 2004, while the reduction for 
cooperating firms was one per cent higher on average.12 A two-sided t-test on 
mean equality in both groups while allowing for unequal variances between the 
two groups indicates that the mean difference is statistically significant at the 5 
per cent level. However, the share of firms with no cost reduction, i.e. the 
censored observations, is rather high. About 70 per cent of the firms sampled 
reported no cost reductions at all. Looking at the other two success measures 
IMIP and NOVP, the t-test shows that the two variables are significantly higher 
(at the 1% significance level) for cooperating firms than for non-cooperating 
ones. The share of sales from new or significantly improved products equals 12 
per cent for the non-cooperating firms while the share is almost twice as large for 
the cooperating firms. The relative difference between the two groups is even 
higher for the share of sales due to market novelties: 3.4 versus 11.6 per cent. 
Overall, the proportions of firms with zero turnover from new products or market 
novelties are 41 and 66 per cent, respectively. 
Let us now turn to co-operation behavior. 32 per cent of the sampled companies 
cooperated during the period 2001 to 2003.13 Co-operations with universities or 
research institutes were predominant. 84 per cent of the cooperating firms 
collaborated with these partners. The shares of firms with cooperative 
agreements with customers and suppliers are just under half the size and amount 
to 42 and 45 per cent, respectively. Almost a quarter of cooperating firms are 
engaged in co-operations with their competitors.  
Looking at the other explanatory variables, we can see that the firms spent on 
average seven thousand Euros per employee on innovation in 2003. A little more 
than half of the firms had R&D employees and almost a quarter of the workforce 
has a university degree. Both shares are higher for cooperating firms which 
indicates that these firms have higher absorptive capacities that might be used for 
their internal innovation processes. The average size of a firm in the sample is 60 
employees. For the average firm, about 18 per cent of the sales were exports in 
2003 and the average firm age was 15 years. Almost 60 per cent of the firms 
sampled are part of a group and 36 per cent are located in Eastern Germany. 
About two thirds of the firms are active in the manufacturing sector. 
                                                 
11 The descriptive statistics of the whole sample can be seen in table 6 (appendix). 
12 Five observations were dropped due to their extremely high cost reduction, up to 80 per cent, in order 
to ensure that the results are not driven by these outliers.  
13 The share of co-operating firms is slightly higher compared to the projected numbers for Germany for 
2003. This is mainly due to the different bases of the percentage. For the projections all innovators of 
2003 are considered. In this sample the firms had to be an innovator in 2004.  
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Table 1: Descriptive Statistics  
 Non-cooperating firms Cooperating firms 
Variable b) Mean Std. dev. Mean Std. dev. 
REDP 2.142 4.754 3.248 6.001 
IMIP 12.385 20.573 19.884 20.412 
NOVP 3.361 9.477 11.563 20.347 
COOP a) 0 0 1 0 
CO_CU a) 0 0 0.425 0.495 
CO_SU a) 0 0 0.456 0.499 
CO_CO a) 0 0 0.230 0.422 
CO_IN a) 0 0 0.836 0.371 
ININT a) 4.167 7.642 13.868 15.470 
ININT2 a) 75.630 314.486 430.592 951.215 
RDEMPD a) 0.359 0.475 0.897 0.297 
HQUAL a) 0.187 0.236 0.342 0.277 
LNEMP 3.951 1.593 4.411 1.687 
EXINT a) 0.142 0.221 0.264 0.274 
LNAGE 2.754 0.732 2.639 0.710 
GROUP 0.537 0.499 0.690 0.463 
EAST 0.323 0.468 0.425 0.495 
IND1 0.057 0.232 0.044 0.206 
IND2 0.049 0.215 0.031 0.174 
IND3 0.093 0.291 0.040 0.196 
IND4 0.091 0.288 0.115 0.320 
IND5 0.195 0.396 0.257 0.438 
IND6 0.068 0.251 0.088 0.285 
IND7 0.030 0.170 0.133 0.340 
IND8 0.068 0.251 0.009 0.094 
IND9 0.068 0.251 0.009 0.094 
IND10 0.059 0.236 0.013 0.115 
IND11 0.148 0.355 0.243 0.430 
IND12 0.076 0.265 0.018 0.132 
# of obs. 473 226 
a) Lagged values 
b) A detailed description of the variables can be found in table 5 (appendix) 
Empirical Model 
Because all our dependent variables are censored, i.e. restricted to the interval 
between 0% and 100%, we use a censored regression or tobit estimation 
procedure to estimate our model. Since the proportion of observations with 100% 
is rather small, i.e. between zero and one per cent contingent on the depended 
variable, we only consider the lower bound in our estimations.14 The tobit is 
                                                 
14 We also estimated the tobit models integrating the upper bound. But the results stay the same since the 
number of upper bound censored observations is fairly small.  
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similar to a probit model in the sense that a latent variable is estimated. The 
formal tobit model in our case is given by:15 
* ' , 1,...,= + =i i iy x i Nβ ε   (1) 
*0 0= ≤i iy if y   (2) 
* * 0= >i i iy y if y   (3) 
The coefficient estimations of tobit models are inconsistent in the presence of 
heteroscedasticity and also lead to biased standard errors. Therefore we conduct a 
Lagrange-Multiplier test on multiplicative heteroscedasticity proposed by 
Greene (2003) after the estimations of the homoscedastic tobit models. The Null-
Hypothesis is that homoscedasticity is present. If heteroscedasticity is detected, 
the tobit model is re-estimated using the exponential function of the variables 
that cause heteroscedasticity as the variance. Finally, a Likelihood-Ratio-Test on 
the joint significance of the variables in the heteroscedasticity term is carried out 
in order to check whether the heteroscedastic tobit model leads to more precise 
results.  
5 Results 
We estimate tobit models including first the overall co-operation dummy 
(COOP) and then the dummies for the four different types of co-operation. The 
results of a Lagrange-Multiplier-Test on group-wise multiplicative 
heteroscedasticity of the industries, size classes and the location “Eastern 
Germany”16 in the models are shown in table 2. The test reveals 
heteroscedasticity of the size class dummies in all specifications. The industry 
and East dummies are only heteroscedastic in specific models. As consequence, 
we estimate the tobit again, thereby controlling for the detected 
heteroscedasticity.17  
                                                 
15 See Greene (2003) for a more detailed description of censored regression models. 
16 These are the variables usually assumed to be heteroscedastic in this setting (see e.g. Czarnitzki and 
Kraft, 2004) 
17 The results of the homoscedastic tobit models can be found in table 8 (appendix). 
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Table 2: LM-test-statistics on heteroscedasticity for all tobit models 
LM-value Tested 
Variable 
Critical value 
REDP IMIP NOVP 
 χ2(df,α)a) (1) (2) (3) (4) (5) (6) 
Industry 
dummies 
χ2(11, 1%)=24.72 48.08*** 47.25*** 11.31 12.11 30.93*** 30.00*** 
Size class 
dummies 
χ2(4, 1%)=13.28 25.16*** 27.10*** 17.73*** 17.87*** 33.97*** 34.45*** 
East χ2(1, 1%)=6.63 3.30* 5.59** 1.15 0.70 0.17 0.07 
Note:  *** (*) indicate significance level of 1% (10%). 
  a) df: degrees of freedom, α: significance level 
Columns (1), (3) and (5) refer to the tobit model with the aggregated co-operation variable 
COOP, columns (2), (4) and (6) to the models with the four different “co-operations” dummies. 
The results of the heteroscedastic tobit regressions are shown in tables 3 and 4. 
Our main concern is whether the co-operation dummies have an impact on 
economic success. The estimations show different results for the general 
engagement in R&D co-operation on the three success measures. The aggregated 
R&D co-operation dummy reveals a significant increase in the cost reductions 
due to process innovations and in the share of sales due to market novelties. 
These are products not only new to the firm but also to the market the firm 
operates in. R&D co-operation was found to have no significant impact on the 
share of sales from product imitations. These products are improved or new to 
the firm but do not include innovations new to the market. They are products 
which already existed in a firms’ market.  
Taking a more detailed look at R&D co-operation, it becomes apparent that 
different co-operation partners have different effects on the specific success 
measures. The structure for the relationship between R&D co-operation and the 
output of process innovations is different to that between co-operation and the 
output of product innovations. 
Regarding the effects of the different co-operation partners on cost reduction 
we find that R&D co-operation with competitors or firms from the same sector 
has a highly significant positive effect, while the overall co-operation dummy 
had only a weakly significant positive impact. On the other hand, co-operations 
with suppliers do not have an impact on success with process innovations. 
External expertise acquired through co-operation with competitors can help firms 
to improve their production processes significantly. Our results provide empirical 
evidence for the arguments put forward by the non-tournament literature that the 
level of cost-reduction achieved is higher if competitors cooperate than if they 
compete in their R&D activities.  
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Table 3: Heteroscedatic tobit regressions with the general co-operation 
dummy 
 (1) (2) (3) (4) (5) (6) 
 REDP IMIP NOVP 
 
Coeff.     (Std. 
err.) 
Marginal 
effect 
Coeff.      
(Std. err.) 
Marginal 
effect 
Coeff.      
(Std. err.) 
Marginal 
effect 
COOP a) 2.361* 0.553 1.982 1.142 5.069** 1.432 
 (1.356)  (2.746)  (2.551)  
ININT a) 0.375** 0.084 0.569** 0.325 0.468* 0.126 
 (0.169)  (0.289)  (0.258)  
ININT2 a) -0.007** -0.002 -0.010* -0.006 -0.002 -0.001 
 (0.004)  (0.005)  (0.005)  
RDEMPD a) 1.779 0.398 14.468*** 8.159 11.517*** 3.071 
 (1.476)  (3.046)  (3.146)  
HQUAL a) -5.583 -1.254 8.793 5.023 14.889** 4.019 
 (4.027)  (6.993)  (7.130)  
LNEMP 1.387*** 0.311 1.664* 0.950 0.039 0.011 
 (0.538)  (0.881)  (0.938)  
EXINT a) -2.452 -0.551 0.908 0.518 8.920* 2.408 
 (2.735)  (5.366)  (4.824)  
LNAGE 0.003 0.001 -3.470** -1.982 -0.572 -0.154 
 (0.797)  (1.634)  (1.553)  
GROUP -0.686 -0.155 -1.333 -0.763 0.670 0.180 
 (1.350)  (2.655)  (2.550)  
EAST -3.373 -0.724 3.899 2.257 -4.105 -1.076 
 (2.069)  (2.800)  (2.633)  
CONSTANT 2.038***  -8.199  -16.173*  
 (0.277)  (7.880)  (8.327)  
Wald-Test on joint 
significance of 
industry dummies 
W(χ2(11))= 
24.04**  
W(χ2(11))=
8.62  
W(χ2(11))= 
21.22**  
# of obs. 699  699  699  
Log-Likelihood -974.518  -2,163.969  -1,274.068  
LR-Test on 
heteroscedasticity 
LR(χ2(16))= 
38.730***  
LR(χ2(4))=  
27.283***  
LR(χ2(15))=  
46.805***  
Note:  *** (**, *) indicate significance level of 1% (5%, 10%). 
  a) Lagged values 
  11 industry dummies are included in regressions but not shown. 
The result that the overall co-operation dummy does not have a significant 
effect on the share of sales from product imitations stays the same when looking 
at the different types of co-operation. No type of co-operation has a significant 
impact on this success measure. It seems not to be beneficial to cooperate on 
R&D in order to improve products or to imitate already existing products. One 
explanation might be that the knowledge required for this type of innovation can 
be obtained through other channels.  
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Table 4: Heteroscedatic tobit regressions with four co-operation dummies 
 (1) (2) (3) (4) (5) (6) 
 REDP IMIP NOVP 
 
Coeff.     (Std. 
err.) 
Marginal 
effect 
Coeff.      
(Std. err.) 
Marginal 
effect 
Coeff.      
(Std. err.) 
Marginal 
effect 
CO_CU a) 2.290 0.548 4.506 2.681 4.249 1.251 
 (1.915)  (3.726)  (3.085)  
CO_SU a) -2.626 -0.528 4.628 2.753 -1.307 -0.348 
 (1.950)  (3.494)  (3.126)  
CO_CO a) 6.437** 1.846 2.911 1.716 -5.346 -1.295 
 (2.545)  (4.333)  (3.725)  
CO_IN a) 2.086 0.482 -5.025 -2.795 7.305** 2.168 
 (1.690)  (3.267)  (3.031)  
ININT a) 0.374** 0.082 0.553* 0.317 0.465* 0.127 
 (0.166)  (0.287)  (0.258)  
ININT2 a) -0.007** -0.002 -0.010** -0.006 -0.003 -0.001 
 (0.004)  (0.005)  (0.005)  
RDEMPD a) 1.721 0.377 15.154*** 8.556 10.716*** 2.884 
 (1.436)  (3.025)  (3.091)  
HQUAL a) -7.576* -1.668 9.541 5.462 14.617** 3.981 
 (4.220)  (6.944)  (6.906)  
LNEMP 1.113** 0.245 1.570* 0.899 -0.193 -0.052 
 (0.520)  (0.879)  (0.924)  
EXINT a) -1.930 -0.425 1.132 0.648 8.503* 2.316 
 (2.760)  (5.367)  (4.774)  
LNAGE 0.147 0.032 -3.348** -1.916 -0.124 -0.034 
 (0.778)  (1.631)  (1.548)  
GROUP -0.565 -0.125 -1.363 -0.782 0.433 0.118 
 (1.318)  (2.644)  (2.530)  
EAST -3.438 -0.723 4.172 2.423 -3.680 -0.976 
 (2.105)  (2.785)  (2.600)  
CONSTANT -8.261**  -7.487  -15.533*  
 (3.937)  (7.832)  (8.077)  
Wald-Test on joint 
significance of 
industry dummies 
W(χ2(11))= 
26.91***  
W(χ2(11))= 
8.28  
W(χ2(11))=  
22.14**  
# of obs. 699  699  699  
Log-Likelihood -970.114  -2,161.288  -1,270.186  
LR-Test on 
heteroscedasticity 
LR(χ2(16))= 
39.716***  
LR(χ2(4))= 
27.138***  
LR(χ2(15))= 
46.174***  
Note:  *** (**, *) indicate significance level of 1% (5%, 10%). 
  a) Lagged values 
  11 industry dummies are included in regressions but not shown. 
The firms that cooperate with universities or research institutions in their R&D 
and innovation activities have a higher share of turnover from market novelties 
than firms that do not co-operation or those cooperating with customers, 
suppliers or competitors. To achieve success with market novelties by co-
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operation, it seems to be particularly important to bring together the expertise and 
knowledge of research institutes and universities with one’s own. The acquisition 
of or conflation with complementary knowledge from basic research is needed 
for fundamental innovations.  
The control variables provide some interesting insight as well. For the 
innovation intensity we find an inverted U-shaped influence on the cost reduction 
and the share of sales from product imitations. The turning point for the inverse 
U can be calculated from the coefficients obtained. It lies at around 25 and 29 
thousand €/employee, respectively. The share from product imitations decreases 
after an innovation intensity of about 29 thousand €/employee. The reason for 
this finding might be that there is a “substitution effect” at work. After the 
threshold has been reached, development activities might get more ambitious and 
lead to some real new products. As a result the firm will have a lower turnover 
share from product imitations and a higher share from market novelties. This can 
be confirmed by the finding regarding the share of turnover from market 
novelties: we find a positive and linear relationship. Hence, with higher 
innovation intensity, success with totally new product innovations always 
increases. However, no economies of scale in developing new technologies are 
found. 
The employment of R&D staff, which implies a long-term R&D orientation, 
has a highly positive impact on both the share of sales with product imitations 
and the share with market novelties. However, the dummy for R&D employees 
does not have a significant effect on cost reductions via process innovations, 
which might indicate that R&D activities deal mainly with product innovations. 
In order to achieve cost reductions, the acquisition of new technology and its 
adaptation to the specific environment within the firm might be the key. R&D is 
not needed for this. The share of highly qualified employees has a positive 
impact on the share of sales attributable to market novelties, underscoring the 
importance of absorptive capacity for the development of genuinely new 
products. 
Larger firms can realize larger cost reductions. They might have a greater 
potential to save costs than small firms, which provides an incentive for them to 
invest money and resources in process innovations. The size variable has a 
positive effect on the share of sales from product imitations. It is insignificant in 
the regression on the dependent variable for market novelties. These findings 
point to the existence of economies of scale in process innovations and the non-
existence of economies of scale in the development of new technologies. 
The export intensity is only positive and significant for market novelties. The 
explanation for this finding is straightforward: Firms which are exposed to 
international competition are forced to develop higher-quality and more novel 
products. This argument is especially valid for a high wage country like 
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Germany. To give an example, the German textile industry almost exclusively 
relies on the development of market novelties, while the production takes place 
in low cost countries (Beise et al., 2002). At the same time the market for real 
innovative products is larger for firms that export their products than for firms 
that do not export.  
Regarding a firm’s age, we can state that the younger the firm the larger the 
share of sales due to product imitations. Since a young firm has not yet been 
active in the market for a long time and might still be at the stage of introducing 
their first products, it is logical that the share of new or significantly improved 
products is higher for these firms. But as the estimates also show, young firms do 
not necessarily introduce market novelties. Being a member of a group has no 
impact on the direct economic success measures. The three measures of success 
also show no significant differences between the Eastern and Western parts of 
Germany. The results of these variables are fairly robust and stay similar to the 
estimates when dummies for the four different types of co-operation are included.  
6 Conclusion 
Our analysis focused on the effects of R&D co-operation on the direct success 
of innovations, as measured by three variables: cost reductions due to process 
innovations, share of sales from product imitations, and share of sales from 
market novelties. The R&D co-operations were distinguished by type of partner: 
customer, supplier, competitors, and research institutions. The study reveals that 
R&D co-operation has a positive effect on the success of process innovations and 
sales of market novelties, but no significant effect on sales of product imitations.  
By distinguishing between co-operations with different types of partners, we 
identify co-operation with competitors to be profitable in terms of cost reduction. 
If firms aim to develop products new to the market, co-operations with research 
institutes are helpful. Our analysis partly confirms the findings of Belderbos et al. 
(2004b) who find a significant positive effect of university co-operation on the 
growth of new-to–the-market sales within a two year period after co-operation. 
However, we found no evidence of any positive effect of competitor cooperation 
on the share of sales from market novelties. R&D co-operations with suppliers 
and customers do not have a significant impact on the three success measures. 
The results show that it is important to look at the specific types of R&D co-
operations because they have different impacts on the direct economic success 
firms achieve with their innovations. 
A question that our results suggest is: why do not all innovative firms cooperate 
on R&D activities with external partners, if it is as beneficial as we have 
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estimated? On the one hand the firm itself might not have the capacity and 
capability to search for a co-operation partner and manage the co-operation; on 
the other hand, there might be no partner available to cooperate with. 
A limitation of this study is that we could not control for the duration of the co-
operation. We observe whether firms are involved in R&D co-operation or not, 
but not when the co-operation started. The chosen lag structure between R&D 
co-operation and its effects, based on a one-year delay, is another constraint of 
our study. It is certainly worth looking at the impact of R&D co-operation over a 
longer period of time. This would provide a better basis for the researchers to 
asses the success of different forms of R&D co-operation than just looking at the 
(extremely) short-term effects.  
The type of partners could also be split up by country of origin. Foreign co-
operation partners might differ in the knowledge and experience they possess and 
could thus have a greater influence on innovative success than domestic ones. 
Whether this is really the case should be addressed in future studies. 
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Appendix 
Table 5: List of constructed variables 
Variable Description 
REDP Reduction of average costs (in %) in 2004 due to new processes introduced during 2002 to 
2004 (in %) 
IMIP Share of turnover in 2004 from imitated products, i.e. new or significantly improved 
products excluding turnover from market novelties, introduced during 2002 to 2004 (in %) 
NOVP Share of turnover in 2004 with market novelties introduced during 2002 to 2004 (in %) 
COOP Co-operative R&D projects in 2001-2003 
CO_CU Co-operative R&D projects with customers in 2001-2003 
CO_SU Co-operative R&D projects with suppliers in 2001-2003 
CO_CO Co-operative R&D projects with competitors in 2001-2003 
CO_IN Co-operative R&D projects with research institutes or universities in 2001-2003 
ININT Innovation intensity (innovation expenditures in thousand EURO/number of employees) in 
2003 
ININT2 Innovation intensity squared 
RDEMPD Firm has R&D employees in 2003 (Dummy) 
HQUAL Share of employees with a higher education degree in 2003 (in %) 
LNEMP Number of employees (in logarithm) in 2004 
EXINT Export intensity (exports/turnover) in 2003 
LNAGE Firm’s age (in logarithm) in 2004 
GROUP Member of a group in 2004 
EAST Located in Eastern Germany (the former GDR) in 2004  
 NACE:   
IND1 10, 14, 26, 
40, 41, 45 
Mining, non-metallic mineral products, electricity, gas, water supply, 
collection, purification and distribution of water, construction 
IND2 15, 17-19 Food, beverages, tobacco; textile, clothes and leather goods 
IND3 20-22, 36, 
37 
Wood, paper, publishing, printing, furniture, jewellery, musical and sport 
instruments, toys,  recycling 
IND4 23-25 Fuels and chemicals, rubber and plastic products 
IND5 27-29, 34, 
35 
Basic metals, fabricated metal, machinery and equipment, motor vehicles and 
components, other transport 
IND6 30-32 Office machinery and computers, electrical machinery, radio, television and 
communication equipment 
IND7 33 Medical, precision, optical instruments, watches  
IND8 50-52 Retail and wholesale trade 
IND9 60-63, 641 Land, water, air transport, supporting transport activities, post activities 
IND10 65-67 Financial intermediation, activities auxiliary to financial intermediation 
IND11 642, 72, 73, 
741-744 
Telecommunication, computer activities, research and development, tax and 
business consultancy, market research, architectural and engineering activities 
and related technical consultancy, technical testing and analysis, advertising 
IND12 70, 71, 745-
748, 90, 921 
Real estate activities, renting of machinery without operator and of personal 
and household goods, labor recruitment, investigation and security activities, 
industrial cleaning, miscellaneous business activities n.e.c., refuse disposal, 
sanitation activities, motion picture  
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Table 6: Descriptive Statistics (699 observations) 
Variable Mean Std. dev. Min Max 
REDP 2.500 5.211 0 40 
IMIP 14.809 20.805 0 100 
NOVP 6.013 14.455 0 100 
COOP a) 0.323 0.468 0 1 
CO_CU a) 0.137 0.344 0 1 
CO_SU a) 0.147 0.355 0 1 
CO_CO a) 0.074 0.263 0 1 
CO_IN a) 0.270 0.444 0 1 
ININT a) 7.303 11.716 0 80.537  
ININT2 a) 190.396 621.410 0 6,486.194 
RDEMPD a) 0.533 0.494 0 1 
HQUAL a) 0.237 0.260 0 1 
LNEMP 4.099 1.637 0 9.116 
EXINT a) 0.181 0.246 0 1 
LNAGE 2.717 0.726 0 5.493 
GROUP 0.587 0.493 0 1 
EAST 0.356 0.479 0 1 
IND1 0.053 0.224 0 1 
IND2 0.043 0.203 0 1 
IND3 0.076 0.265 0 1 
IND4 0.099 0.298 0 1 
IND5 0.215 0.411 0 1 
IND6 0.074 0.263 0 1 
IND7 0.063 0.243 0 1 
IND8 0.049 0.215 0 1 
IND9 0.049 0.215 0 1 
IND10 0.044 0.206 0 1 
IND11 0.179 0.383 0 1 
IND12 0.057 0.232 0 1 
a)Lagged values 
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Table 7: Homoscedastic tobit regressions  
 (1) (2) (3) (4) (5) (6) 
 REDP IMIP NOVP 
 
Coeff. 
(Std. err.) 
Coeff. 
(Std. err.) 
Coeff. 
(Std. err.) 
Coeff. 
(Std. err.) 
Coeff. 
(Std. err.) 
Coeff. 
(Std. err.) 
COOP a) 1.696 - 1.773 - 7.839*** - 
 (1.621) - (3.020) - (3.058) - 
CO_CU a) - 2.350 - 5.213 - 4.915 
 - (2.129) - (3.968) - (3.775) 
CO_SU a) - -0.255 - 5.421 - 1.228 
 - (2.038) - (3.753) - (3.650) 
CO_CO a) - 6.038** - 2.764 - -4.769 
 - (2.491) - (4.762) - (4.551) 
CO_IN a) - -0.433 - -5.439 - 9.604*** 
 - (1.937) - (3.566) - (3.563) 
ININT a) 0.406** 0.398** 0.608** 0.595** 0.680** 0.663** 
 (0.179) (0.180) (0.293) (0.292) (0.287) (0.285) 
ININT2 a) -0.008** -0.009** -0.010** -0.011** -0.006 -0.006 
 (0.004) (0.004) (0.005) (0.005) (0.005) (0.005) 
RDEMPD a) 0.638 0.626 15.376*** 15.965*** 11.381*** 10.451*** 
 (1.741) (1.717) (3.229) (3.197) (3.527) (3.479) 
HQUAL a) -3.634 -4.266 7.877 8.552 18.328*** 18.138*** 
 (3.907) (3.902) (6.703) (6.680) (6.857) (6.811) 
LNEMP 1.112** 0.974** 0.851 0.797 -0.911 -1.038 
 (0.498) (0.495) (0.919) (0.920) (0.941) (0.937) 
EXINT a) -0.110 0.224 -1.673 -2.004 8.082 6.829 
 (3.165) (3.144) (6.057) (6.047) (5.884) (5.850) 
LNAGE 0.422 0.458 -4.360** -4.361** -1.948 -1.675 
 (0.969) (0.961) (1.793) (1.788) (1.875) (1.859) 
GROUP 0.230 0.288 -1.102 -1.288 1.839 1.642 
 (1.427) (1.414) (2.613) (2.603) (2.782) (2.761) 
EAST -0.399 -0.097 3.198 3.330 -6.548** -6.336** 
 (1.563) (1.550) (2.832) (2.813) (3.017) (2.986) 
CONSTANT -16.286*** -15.243*** -2.045 -1.541 -11.955 -12.113 
 (4.504) (4.453) (8.058) (8.042) (8.454) (8.409) 
Wald-Test on joint 
significance of 
industry dummies 
W(χ2(11))= 
15.25  
W(χ2(11))= 
14.90 
W(χ2(11))= 
7.71 
W(χ2(11))= 
7.76 
W(χ2(11))=  
26.93*** 
W(χ2(11))= 
26.90*** 
# of obs. 699 699 699 699 699 699 
Log-Likelihood -993.883 -989.972 -2,177.610 -2,174.857 -1,297.471 -1,293.273 
Note:  *** (**, *) indicate significance level of 1% (5%, 10%). 
  a) Lagged values 
  11 industry dummies are included in regressions but not shown 
 
 
